Sudarshan Chemical Industries Limited announced the approval of its unaudited standalone and consolidated financial results for the quarter and half-year ended September 30, 2026. The Board also approved the appointment of Mr. Amit Deshpande as Company Secretary, Compliance Officer, Nodal Officer, and Key Managerial Personnel, effective November 6, 2026. Additionally, the trading window for securities will reopen on November 9, 2026.
Financial Results Approved
Sudarshan Chemical Industries Limited’s Board of Directors convened on Friday, November 6, 2026, to review and approve the unaudited financial results. The Board sanctioned the standalone and consolidated financial results for the quarter and half-year ended September 30, 2026, along with the accompanying Limited Review Report from M/s. S R B C & CO LLP.
These financial statements were previously reviewed and recommended by the Audit Committee. The results will be uploaded on the company’s website, www.sudarshan.com, and published in the prescribed format in newspapers.
Key Appointments Made
In a significant governance move, the Board, upon the recommendation of the Nomination and Remuneration Committee, approved the appointment of Mr. Amit Deshpande (ACS: 17551) as the Company Secretary, Compliance Officer, Nodal Officer, and Key Managerial Personnel. This appointment is effective from November 6, 2026, and will be in addition to his existing roles as General Counsel and Senior Management Personnel.
Changes to authorization under Regulation 30(5) of SEBI Listing Regulations, 2015, were also approved, detailing officials authorized to determine materiality and make disclosures.
Trading Window Reopening
Further to the financial results announcement, the trading window for dealing in the Company’s securities will open on Monday, November 9, 2026. This reopening is set for forty-eight hours after the declaration of the unaudited financial results for the quarter and half-year ended September 30, 2026.
Source: BSE
